Brokerages expect Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to report sales of $1.42 billion for the current quarter, according to Zacks Investment Research. Ten analysts have provided estimates for Alexion Pharmaceuticals’ earnings, with the highest sales estimate coming in at $1.49 billion and the lowest estimate coming in at $1.34 billion. Alexion Pharmaceuticals reported sales of $1.26 […]
